Follow
Simone Lista
Simone Lista
i+HeALTH Strategic Research Group, Miguel de Cervantes European University
Verified email at uemc.es
Title
Cited by
Cited by
Year
Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria
B Dubois, H Hampel, HH Feldman, P Scheltens, P Aisen, S Andrieu, ...
Alzheimer's & Dementia 12 (3), 292-323, 2016
17272016
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
H Hampel, SE O’Bryant, JL Molinuevo, H Zetterberg, CL Masters, S Lista, ...
Nature Reviews Neurology 14 (11), 639-652, 2018
5692018
The β-secretase BACE1 in Alzheimer’s disease
H Hampel, R Vassar, B De Strooper, J Hardy, M Willem, N Singh, J Zhou, ...
Biological psychiatry 89 (8), 745-756, 2021
4212021
Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia
RER Slot, SAM Sikkes, J Berkhof, H Brodaty, R Buckley, E Cavedo, ...
Alzheimer's & Dementia 15 (3), 465-476, 2019
3062019
Blood-based biomarkers in Alzheimer disease: current state of the science and a novel collaborative paradigm for advancing from discovery to clinic
SE O'Bryant, MM Mielke, RA Rissman, S Lista, H Vanderstichele, ...
Alzheimer's & Dementia 13 (1), 45-58, 2017
2622017
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World …
P Lewczuk, P Riederer, SE O’bryant, MM Verbeek, B Dubois, PJ Visser, ...
The world journal of biological psychiatry 19 (4), 244-328, 2018
2452018
Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research
SE O'Bryant, V Gupta, K Henriksen, M Edwards, A Jeromin, S Lista, ...
Alzheimer's & Dementia 11 (5), 549-560, 2015
2362015
A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer's disease
H Hampel, F Caraci, AC Cuello, G Caruso, R Nisticò, M Corbo, F Baldacci, ...
Frontiers in immunology 11, 456, 2020
2342020
Exercise benefits on Alzheimer’s disease: State-of-the-science
PL Valenzuela, A Castillo-García, JS Morales, P de la Villa, H Hampel, ...
Ageing research reviews 62, 101108, 2020
2222020
Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease
SJ Teipel, M Grothe, S Lista, N Toschi, FG Garaci, H Hampel
Medical Clinics 97 (3), 399-424, 2013
2152013
Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study
B Dubois, S Epelbaum, F Nyasse, H Bakardjian, G Gagliardi, ...
The Lancet Neurology 17 (4), 335-346, 2018
1942018
EEG evidence of compensatory mechanisms in preclinical Alzheimer’s disease
S Gaubert, F Raimondo, M Houot, MC Corsi, L Naccache, J Diego Sitt, ...
Brain 142 (7), 2096-2112, 2019
1692019
A common challenge in older adults: Classification, overlap, and therapy of depression and dementia
T Leyhe, CF Reynolds III, T Melcher, C Linnemann, S Klöppel, K Blennow, ...
Alzheimer's & dementia 13 (1), 59-71, 2017
1692017
Development of biomarkers to chart all Alzheimer’s disease stages: the royal road to cutting the therapeutic Gordian Knot
H Hampel, S Lista, ZS Khachaturian
Alzheimer's & dementia 8 (4), 312-336, 2012
1502012
Revolution of Alzheimer precision neurology. Passageway of systems biology and neurophysiology
H Hampel, N Toschi, C Babiloni, F Baldacci, KL Black, ALW Bokde, ...
Journal of Alzheimer's Disease 64 (s1), S47-S105, 2018
1442018
Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020
H Hampel, S Lista, SJ Teipel, F Garaci, R Nisticò, K Blennow, ...
Biochemical pharmacology 88 (4), 426-449, 2014
1412014
Blood and plasma-based proteomic biomarker research in Alzheimer's disease
S Lista, F Faltraco, D Prvulovic, H Hampel
Progress in neurobiology 101, 1-17, 2013
1392013
CSF biomarkers for the differential diagnosis of Alzheimer's disease: a large-scale international multicenter study
M Ewers, N Mattsson, L Minthon, JL Molinuevo, A Antonell, J Popp, ...
Alzheimer's & Dementia 11 (11), 1306-1315, 2015
1362015
Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease
A Vergallo, L Mégret, S Lista, E Cavedo, H Zetterberg, K Blennow, ...
Alzheimer's & Dementia 15 (6), 764-775, 2019
1312019
A precision medicine initiative for Alzheimer’s disease: the road ahead to biomarker-guided integrative disease modeling
H Hampel, SE O’Bryant, S Durrleman, E Younesi, K Rojkova, ...
Climacteric 20 (2), 107-118, 2017
1252017
The system can't perform the operation now. Try again later.
Articles 1–20